Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Efficacy of lithium in schizophrenia.

Dube S, Sethi BB.

Indian J Psychiatry. 1981 Jul;23(3):193-9.

2.

Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine.

Lieberman JA, Phillips M, Gu H, Stroup S, Zhang P, Kong L, Ji Z, Koch G, Hamer RM.

Neuropsychopharmacology. 2003 May;28(5):995-1003. Epub 2003 Mar 26.

3.

Lithium addition to neuroleptic treatment in chronic schizophrenia: a randomized, double-blind, placebo-controlled, cross-over study.

Terao T, Oga T, Nozaki S, Ohta A, Ohtsubo Y, Yamamoto S, Zamami M, Okada M.

Acta Psychiatr Scand. 1995 Sep;92(3):220-4.

PMID:
7484202
4.

Relationships between drug concentrations in serum and CSF, clinical effects and monoaminergic variables in schizophrenic patients treated with sulpiride or chlorpromazine.

Alfredsson G, Bjerkenstedt L, Edman G, Härnryd C, Oxenstierna G, Sedvall G, Wiesel FA.

Acta Psychiatr Scand Suppl. 1984;311:49-74.

PMID:
6199949
5.

Levomepromazine versus chlorpromazine in treatment-resistant schizophrenia: a double-blind randomized trial.

Lal S, Thavundayil JX, Nair NP, Annable L, Ng Ying Kin NM, Gabriel A, Schwartz G.

J Psychiatry Neurosci. 2006 Jul;31(4):271-9.

6.

A double-blind comparative study of clozapine versus chlorpromazine on Chinese patients with treatment-refractory schizophrenia.

Hong CJ, Chen JY, Chiu HJ, Sim CB.

Int Clin Psychopharmacol. 1997 May;12(3):123-30.

PMID:
9248867
7.
8.

Use of carbamazepine in acute psychosis: a controlled study.

Lenzi A, Lazzerini F, Grossi E, Massimetti G, Placidi GF.

J Int Med Res. 1986;14(2):78-84.

PMID:
3084316
9.
10.

Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia : an 8-week, randomized, double-blind, placebo-controlled study.

Modabbernia A, Rezaei F, Salehi B, Jafarinia M, Ashrafi M, Tabrizi M, Hosseini SM, Tajdini M, Ghaleiha A, Akhondzadeh S.

CNS Drugs. 2013 Jan;27(1):57-65. doi: 10.1007/s40263-012-0022-1.

PMID:
23233269
12.

Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial.

Barnes TR, Leeson VC, Paton C, Costelloe C, Simon J, Kiss N, Osborn D, Killaspy H, Craig TK, Lewis S, Keown P, Ismail S, Crawford M, Baldwin D, Lewis G, Geddes J, Kumar M, Pathak R, Taylor S.

Health Technol Assess. 2016 Apr;20(29):1-46. doi: 10.3310/hta20290.

13.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
14.

Effects of sulpiride and chlorpromazine on depressive symptoms in schizophrenic patients--relationship to drug concentrations.

Alfredsson G, Härnryd C, Wiesel FA.

Psychopharmacology (Berl). 1984;84(2):237-41.

PMID:
6438683
15.

Antipsychotic effects of lithium in schizophrenia.

Alexander PE, van Kammen DP, Bunney WE Jr.

Am J Psychiatry. 1979 Mar;136(3):283-7.

PMID:
369396
16.

Serum neuroleptic and prolactin levels in schizophrenic patients and clinical response.

Meltzer HY, Busch DA, Fang VS.

Psychiatry Res. 1983 Aug;9(4):271-83.

PMID:
6580660
17.

Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study.

Keck PE, Orsulak PJ, Cutler AJ, Sanchez R, Torbeyns A, Marcus RN, McQuade RD, Carson WH; CN138-135 Study Group..

J Affect Disord. 2009 Jan;112(1-3):36-49. doi: 10.1016/j.jad.2008.05.014. Epub 2008 Oct 2.

PMID:
18835043
19.

Trials of lithium, chlorpromazine and amitriptyline in schizoaffective patients.

Brockington IF, Kendell RE, Kellett JM, Curry SH, Wainwright S.

Br J Psychiatry. 1978 Aug;133:162-8.

PMID:
354733
20.

Supplemental Content

Support Center